Sg3 Management, LLC Novo Cure LTD Call Options Transaction History

Sg3 Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $1.41 Million - $1.88 Million	22,000 New	22,000 $1.61 Million
Q2 2022 Aug 15, 2022	SELL	$56.6 - $89.9 $2.25 Million - $3.57 Million	-39,700 Reduced 83.23%	8,000 $556,000
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $9.16 Million - $12.9 Million	-152,300 Reduced 76.15%	47,700 $3.95 Million
Q4 2021 Feb 15, 2022	BUY	$75.08 - $121.99 $12.8 Million - $20.7 Million	170,000 Added 566.67%	200,000 $15 Million
Q2 2021 Aug 16, 2021	BUY	$130.4 - $225.58 $3.91 Million - $6.77 Million	30,000 New	30,000 $6.66 Million

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.15B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.